Exploring a Novel Method to Determine Antisense Oligonucleotides (ASOs)
This presentation shares a highly efficient method for determining antisense oligonucleotides (ASOs) in human blood.
The technique combines Mitra® VAMS and hybridization LC-MS/MS, revolutionizing ASO quantification. Its key advantage is using Mitra® VAMS for remote sampling, enabling convenient and accurate data collection from micro samples. This method creates possibilities for decentralized clinical trials, facilitating research and development.
We invite you to explore the potential of this bioanalytical workflow and its potential.
Speak with one of our bioanalytical experts to find out how we can support you.
You may also be interested in the below resources:
Webpages:
• Microsampling Capabilities
• Oligonucleotide Capabilities
• The Altascientist: Microsampling in Drug Development